Herantis Pharma Oyj (HRTIS.HE) - Stock Prices, Stock Peers & Analysis

Home
HRTIS.HE

Company Name	Herantis Pharma Oyj
Symbol	HRTIS.HE
Currency	EUR
Price	1.69
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	28,631,304
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.3 - 3.04
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Antti Vuolanto D.Sc. (Tech)
Website	https://www.herantis.com

An error occurred while fetching data.

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative